• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

几种用于估计子宫颈癌治疗成功率的参数统计模型的检验。

A test of several parametic statistical models for estimating success rate in the treatment of carcinoma cervix uteri.

作者信息

Mould R F, Boag J W

出版信息

Br J Cancer. 1975 Nov;32(5):529-50. doi: 10.1038/bjc.1975.259.

DOI:10.1038/bjc.1975.259
PMID:1212415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2024799/
Abstract

The parametric statistical models discussed include all those which have previously been described in the literature (Boag, 1948-lognormal; Berkson and Gage, 1952-negative exponential; Haybittle, 1959-extrapolated actuarial) and the basic data used to test the models comprised some 3000 case histories of patients treated between 1945 and 1962. The histories were followed up during the period treated between 1945 and 1962. The histories were followed up during the period 1969-71 and thus provided adequate information to validate long-term survival fractions predicted using short-term follow-up data. The results with the log-normal model showed that for series of staged carcinoma cervix patients treated during a 5-year period, satisfactory estimates of long-term survival fractions could be predicted after a minimum waiting period of 3 years for stages I and II, and 2 years for stage III. The model should be used with a value assumed for the lognormal paramater S in the range S = 0.35 to S = 0.40. Although alternative models often gave adequate predictions, the lognormal proved to be the most consistent model. This model may therefore now be used with more confidence for prospective studies on carcinoma cervix series and can provide good estimates of long-term survival fractions several years earlier than would otherwise be possible.

摘要

所讨论的参数统计模型包括文献中先前描述过的所有模型(博阿格,1948年——对数正态分布;伯克森和盖奇,1952年——负指数分布;海比特尔,1959年——外推精算模型),用于检验这些模型的基础数据包括1945年至1962年间接受治疗的约3000例患者的病历。这些病历在1945年至1962年的治疗期间进行了随访。在1969年至1971年期间对这些病历进行了随访,从而提供了足够的信息来验证使用短期随访数据预测的长期生存概率。对数正态模型的结果表明,对于在5年期间接受治疗的分期宫颈癌患者系列,对于I期和II期患者,最短等待3年后,对于III期患者,最短等待2年后,可以预测出令人满意的长期生存概率估计值。该模型应使用对数正态参数S在S = 0.35至S = 0.40范围内的假设值。虽然其他模型通常也能给出足够的预测,但对数正态模型被证明是最一致的模型。因此,现在可以更有信心地将该模型用于宫颈癌系列的前瞻性研究,并且可以比其他方法提前数年提供良好的长期生存概率估计。

相似文献

1
A test of several parametic statistical models for estimating success rate in the treatment of carcinoma cervix uteri.几种用于估计子宫颈癌治疗成功率的参数统计模型的检验。
Br J Cancer. 1975 Nov;32(5):529-50. doi: 10.1038/bjc.1975.259.
2
Distribution of survival times of 12,000 head and neck cancer patients who died with their disease.12000例死于头颈癌患者的生存时间分布情况。
Br J Cancer. 1976 Aug;34(2):180-90. doi: 10.1038/bjc.1976.141.
3
Methodology to predict long-term cancer survival from short-term data using Tobacco Cancer Risk and Absolute Cancer Cure models.使用烟草癌症风险模型和绝对癌症治愈模型从短期数据预测癌症长期生存的方法。
Phys Med Biol. 2002 Nov 21;47(22):3893-924. doi: 10.1088/0031-9155/47/22/301.
4
High-dose-rate brachytherapy in uterine cervical carcinoma.子宫颈癌的高剂量率近距离放射治疗
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):125-30. doi: 10.1016/j.ijrobp.2004.09.017.
5
Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.基于铱192高剂量率近距离放疗的子宫颈癌根治性放疗:维也纳大学医院研究结果报告(1993 - 1997年)及其与ICRU 38建议下前期情况的对比
Cancer Radiother. 2000 Mar-Apr;4(2):159-72. doi: 10.1016/S1278-3218(00)88900-3.
6
[Statistical study of a series of 672 cases of carcinoma of the uterine cervix. Results and complications according to age and modalities of treatment].[672例子宫颈癌病例的统计学研究。根据年龄和治疗方式的结果及并发症]
Bull Cancer. 1995 Jul;82(7):568-81.
7
Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.子宫颈癌。I. 总治疗时间延长及近距离放疗时机对放射治疗结局的影响。
Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1275-88. doi: 10.1016/0360-3016(95)00220-S.
8
An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.一项关于使用外照射放疗和单一线源近距离放疗技术治疗子宫颈癌的审计。
Br J Radiol. 1997 Dec;70(840):1259-69. doi: 10.1259/bjr.70.840.9505845.
9
[Structure, treatment and success of treatment in invasive carcinomas of the uterine cervix].
Jugosl Ginekol Opstet. 1979;19(1-2):21-30.
10
Long term follow-up results of high-dose rate remote afterloading intracavitary radiation therapy for carcinoma of the uterine cervix.高剂量率后装腔内放射治疗子宫颈癌的长期随访结果
Strahlenther Onkol. 1994 May;170(5):269-76.

引用本文的文献

1
A statistical model for cancer host survival.癌症宿主生存的统计模型。
Ir J Med Sci. 1979 Dec;148(1):261-6. doi: 10.1007/BF02938095.
2
Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.局部区域型肝外胆管癌的多模态治疗:一项基于人群的分析。
Cancer. 2009 Nov 15;115(22):5175-83. doi: 10.1002/cncr.24572.
3
Short- and long-term cause-specific survival of patients with inflammatory breast cancer.炎性乳腺癌患者的短期和长期特定病因生存率。
BMC Cancer. 2005 Oct 22;5:137. doi: 10.1186/1471-2407-5-137.
4
Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database.评估癌症患者统计学治愈所需的最短随访时间:使用监测、流行病学与最终结果(SEER)数据库中42个癌症部位的数据进行验证
BMC Cancer. 2005 May 17;5:48. doi: 10.1186/1471-2407-5-48.
5
Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries.转移性乳腺癌患者的生存情况:来自两个监测、流行病学和最终结果(SEER)登记处的20年数据。
BMC Cancer. 2004 Sep 2;4:60. doi: 10.1186/1471-2407-4-60.
6
Squamous carcinoma of the head and neck: cured fraction and median survival time as functions of age, sex, histologic type, and node status.头颈部鳞状细胞癌:治愈分数及中位生存时间与年龄、性别、组织学类型和淋巴结状态的关系。
Br J Cancer. 1993 May;67(5):1071-5. doi: 10.1038/bjc.1993.196.
7
The biology of haematogenous metastasis in human uveal malignant melanoma.人类葡萄膜恶性黑色素瘤血行转移的生物学特性
Virchows Arch A Pathol Anat Histopathol. 1993;422(6):433-7. doi: 10.1007/BF01606450.
8
Assessing the impact of adjuvant therapy on cure rate for stage 2 breast carcinoma.评估辅助治疗对二期乳腺癌治愈率的影响。
Br J Cancer. 1993 Jul;68(1):115-8. doi: 10.1038/bjc.1993.296.
9
A model of long-term survival following adjuvant therapy for stage 2 breast cancer.2期乳腺癌辅助治疗后的长期生存模型。
Br J Cancer. 1993 Dec;68(6):1167-70. doi: 10.1038/bjc.1993.498.
10
On the utility of the lognormal model for analysis of breast cancer survival in Sweden 1961-1973.关于对数正态模型在分析1961 - 1973年瑞典乳腺癌生存率中的应用
Br J Cancer. 1985 Dec;52(6):875-83. doi: 10.1038/bjc.1985.272.

本文引用的文献

1
The early estimation of the results of treatment for cancer.癌症治疗结果的早期评估。
Br J Radiol. 1960 Aug;33:502-7. doi: 10.1259/0007-1285-33-392-502.
2
The estimation of the proportion of patients cured after treatment for cancer of the breast.乳腺癌治疗后治愈患者比例的估计。
Br J Radiol. 1959 Nov;32:725-33. doi: 10.1259/0007-1285-32-383-725.
3
Maximum utilization of the life table method in analyzing survival.在分析生存情况时最大限度地利用生命表法。
J Chronic Dis. 1958 Dec;8(6):699-712. doi: 10.1016/0021-9681(58)90126-7.
4
Carcinoma of the vulva. Cure after operative therapy evaluated in accordance with Boag's statistical method.外阴癌。根据博阿格统计方法评估手术治疗后的治愈率。
Dan Med Bull. 1968 Dec;15(10):296-301.